Lexaria Bioscience Corp. (LEXX): Net Income
-$11.90M
Year ended 2025-08-31
-$7.73M
Trailing 12 months to 2026-05-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-08-31 | -$11.90M | n/m | 2025-11-28, From 2024-09-01 |
| 2024-08-31 | -$5.80M | n/m | 2025-11-28, From 2023-09-01 |
| 2023-08-31 | -$6.66M | n/m | 2024-11-26, From 2022-09-01 |
| 2022-08-31 | -$7.27M | n/m | 2023-11-20, From 2021-09-01 |
| 2021-08-31 | -$4.03M | n/c | 2022-11-28, From 2020-09-01 |
| 2020-08-31 | -$4.08M | n/m | 2021-11-29, From 2019-09-01 |
| 2019-08-31 | -$4.16M | n/m | 2020-10-15, From 2018-09-01 |
| 2018-08-31 | -$6.61M | n/m | 2019-11-14, From 2017-09-01 |
| 2017-08-31 | -$1.93M | n/m | 2018-11-14, From 2016-09-01 |
| 2016-08-31 | -$1.28M | n/m | 2018-11-14, From 2015-09-01 |
| 2015-08-31 | -$1.98M | n/m | 2015-11-27, From 2014-09-01 |
| 2014-08-31 | -$1.56M | n/a | 2015-11-27, From 2013-09-01 |
| No annual figure between 2011-10-31 and 2014-08-31. | |||
| 2011-10-31 | -$538.2K | n/m | 2012-01-30, From 2010-11-01 |
| 2010-10-31 | -$552.5K | n/a | 2012-01-30, From 2009-11-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | -$11.90M | n/m |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | -$10.70M | n/m |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | -$69.90M | n/m |
| Hyperion Defi, Inc. (HYPD) | 2025-12-31 | -$45.31M | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | -$14.03M | n/m |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$18.63M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | -$7.75M | n/m |
| Rallybio Corp (RLYB) | 2025-12-31 | -$8.98M | n/m |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | -$26.48M | n/m |
Compare LEXX, PMHS, BTAIQ, HYPD side by side · Screen every company in Pharmaceutical Preparations ↗